Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
GSK2256098
i
Other names:
GSK2256098, GSK 2256098, GTPL7939, GTPL-7939, GSK-2256098, GTPL 7939
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
GSK
Drug class:
FAK inhibitor
Related drugs:
‹
defactinib (8)
LY294002 (7)
AZD0530 (7)
VS-4718 (5)
APG-2449 (4)
IN10018 (3)
PF-562271 (1)
SY-707 (1)
CEP-37440 (0)
FAK-JAK 2 dual Inhib (0)
NVP-TAE226 (0)
PF-573228 (0)
defactinib (8)
LY294002 (7)
AZD0530 (7)
VS-4718 (5)
APG-2449 (4)
IN10018 (3)
PF-562271 (1)
SY-707 (1)
CEP-37440 (0)
FAK-JAK 2 dual Inhib (0)
NVP-TAE226 (0)
PF-573228 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
NF2 mutation
Meningioma
NF2 mutation
Meningioma
GSK2256098
Sensitive: C3 – Early Trials
GSK2256098
Sensitive
:
C3
GSK2256098
Sensitive: C3 – Early Trials
GSK2256098
Sensitive
:
C3
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.